Positive results from trial of Arecor’s insulin candidate AT247
Therapy demonstrates significantly accelerated insulin absorption and early exposure
Read More
Tag: Arecor
Arecor granted European patents to protect Humira formulations
Patents show potential of innovative Arestat technology and the development of enhanced formulations
Read More
Hikma, Arecor set to co-develop new injectable meds
The product will be officially announced prior to launch.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
